Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
10.68
-0.31 (-2.82%)
Nov 20, 2024, 4:00 PM EST - Market closed
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $60.60 million as of November 21, 2024. Its market cap has decreased by -54.95% in one year.
Market Cap
60.60M
Enterprise Value
43.31M
1-Year Change
-54.95%
Ranking
Category
Stock Price
$10.68
Market Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $60.60M, a decrease of -71.85%. That is a compound annual growth rate of -11.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 63.30M | 21.03% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| enVVeno Medical | 63.30M |
| Metagenomi | 63.25M |
| Hyperfine | 63.15M |
| X4 Pharmaceuticals | 62.76M |
| Spero Therapeutics | 62.70M |
| Champions Oncology | 61.85M |
| InterCure | 61.72M |
| VolitionRx | 61.71M |